MANKAL PHARMACEUTICAL PRIVATE LIMITED - Key Persons
Dr Sarasija is a Project Director at IDBR, Bangalore and also a co-founder of start-up company RGV Research & Innovations Pvt. Ltd for research in safe and efficacious medicine. She has been working for over two decades in drug delivery research including nanotechnology with funding from Government of India grants from CSIR, AICTE, DST, DBT; Wellcome Trust, DAAD and has collaborated with institutions and industries in India and abroad. Dr Sarasija is a recipient of several national and international fellowships and awards including DAAD fellowship, Career Award for Young Teachers from AICTE, Wellcome Trust fellowship, STARS award for excellence in Teaching and Research by American Alumni of Govt College of Pharmacy and Woman of the Year 2015 Award by APTI. Dr Sarasija has guided 65 M. Pharm, 11 PhD scholars, filed thirteen patents (seven patents granted including one PCT) and has published above 100 research papers in peer-reviewed journals and presentations in national and international conferences; with seven Best papers awards in conferences and journals. She has published two books on Pharmaceutical Engineering and several book chapters on nanotechnology Dr. Sarasija focus is research and consultancy in drug delivery research particularly nanotechnology for developing safe and efficacious commercially viable products
Dr. Sumanta Kumar Goswami studied Pharmacy and worked in pharmaceutical company and contract research organization. He has experience in drug discovery, development and manufacturing. Currently, he works as a postdoctoral researcher at the University of Alabama, Birmingham, USA. Prior to this he worked as postdoc in University of California, Drexel University College of medicine, The Ohio state University Wexner medical center, Northeastern University.
Mr. Bijay Kumar Parida, has 14 years of experience in sales and Marketing, distribution management, Business development and as a Business relationship manager.
Additionally, Mr. Parida has specialty in New product launch and pre-launch masterminding across the therapeutic category and dosage forms.